Journal of Lipid Research, Vol 38, 892-903, Copyright © 1997 by Lipid Research, Inc.

ARTICLES

Human lysosomal acid lipase/cholesteryl ester hydrolase and human gastric lipase: identification of the catalytically active serine, aspartic acid, and histidine residues

P Lohse, S Chahrokh-Zadeh, P Lohse and D Seidel
Department of Clinical Chemistry, Grosshadern Clinic, University of Munich, Germany.

Human lysosomal acid lipase/cholesteryl ester hydrolase (HLAL), human gastric lipase (HGL), and rat lingual lipase (RLL) constitute a family of mammalian lipases characterized by an acidic pH optimum. HGL and RLL are secreted by the chief cells of the stomach and by the serous von Ebner's glands of the tongue, respectively, and hydrolyze dietary longchain triglycerides in the gastrointestinal tract. HLAL, in contrast, catalyzes the intralysosomal degradation of both triglycerides and cholesteryl esters in virtually all cells except erythrocytes. All three enzymes are proposed to be serine esterases with a catalytic Ser-Asp-His triad similar to other lipases, despite their sensitivity towards sulfhydryl modifying reagents. To investigate the role of conserved serine, aspartic acid, and histidine residues in HLAL and HGL, we constructed 24 mutant lipases with single amino acid substitutions using the site-directed mutagenesis approach. Our combined data strongly support the conclusion that Ser153, Asp324, and His355 are components of the catalytic triad of HLAL and HGL. Structural integrity of the conserved His-Gly dipeptide of lipases also appears to be important for neutral lipid hydrolysis, as replacement of His65 by glutamine abolished HLAL and HGL enzymic activity. Substitution of HLAL residues Asp93, Asp130, and Asp328 with glycine, in contrast, had a more pronounced impact on cholesteryl oleate hydrolysis than on triglyceride hydrolysis. These results provide new insights into the structural basis of HLAL and HGL function.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Das, M. A. Davis, and L. L. Rudel Identification of putative active site residues of ACAT enzymes J. Lipid Res., August 1, 2008; 49(8): 1770 - 1781. [Abstract] [Full Text] [PDF]

				R. Koffel, R. Tiwari, L. Falquet, and R. Schneiter The Saccharomyces cerevisiae YLL012/YEH1, YLR020/YEH2, and TGL1 Genes Encode a Novel Family of Membrane-Anchored Lipases That Are Required for Steryl Ester Hydrolysis Mol. Cell. Biol., March 1, 2005; 25(5): 1655 - 1668. [Abstract] [Full Text] [PDF]

				H. Du, S. Schiavi, N. Wan, M. Levine, D. P. Witte, and G. A. Grabowski Reduction of Atherosclerotic Plaques by Lysosomal Acid Lipase Supplementation Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 147 - 154. [Abstract] [Full Text] [PDF]

				H. Du, S. Schiavi, M. Levine, J. Mishra, M. Heur, and G. A. Grabowski Enzyme therapy for lysosomal acid lipase deficiency in the mouse Hum. Mol. Genet., August 1, 2001; 10(16): 1639 - 1648. [Abstract] [Full Text] [PDF]

				O. Zschenker, N. Jung, J. Rethmeier, S. Trautwein, S. Hertel, M. Zeigler, and D. Ameis Characterization of lysosomal acid lipase mutations in the signal peptide and mature polypeptide region causing Wolman disease J. Lipid Res., July 1, 2001; 42(7): 1033 - 1040. [Abstract] [Full Text] [PDF]

				P. Lohse, S. Maas, P. Lohse, M. Elleder, J. M. Kirk, G. T. N. Besley, and D. Seidel Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease J. Lipid Res., January 1, 2000; 41(1): 23 - 31. [Abstract] [Full Text]

				A. Roussel, S. Canaan, M.-P. Egloff, M. Riviere, L. Dupuis, R. Verger, and C. Cambillau Crystal Structure of Human Gastric Lipase and Model of Lysosomal Acid Lipase, Two Lipolytic Enzymes of Medical Interest J. Biol. Chem., June 11, 1999; 274(24): 16995 - 17002. [Abstract] [Full Text] [PDF]

				P. Lohse, S. Maas, P. Lohse, A. C. Sewell, O. P. van Diggelen, and D. Seidel Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease J. Lipid Res., February 1, 1999; 40(2): 221 - 228. [Abstract] [Full Text]